Copyright
©The Author(s) 2015.
World J Gastrointest Pathophysiol. Nov 15, 2015; 6(4): 150-158
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.150
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.150
Genes | Encoded protein | Mechanism of action | Ref. |
Mendelian syndromes | |||
FBN1 (Marfan syndrome) | Fibrillin | Alteration of TGF-β pathway | [19] |
COL (Elher-Danlos syndrome) | Collagen | Alteration of TGF-β pathway | [19] |
TGFBR (Loeys-Dietz syndrome) | TGF-β-promoters | Alteration of TGF-β pathway | [21] |
STAT3 (Iper-IgE syndrome) | Transcription activator 3 | Aberrant cytokines production | [18] |
DSG1 (SAM) | Desmoglein1 | Loss of cell-cell adhesion | [23] |
EoE-associated genetic variants | |||
CCL26 | Eotaxin-3 | Eosinophilic chemo-attraction | [25] |
FLG | Filaggrin | Epithelium-ECM interaction | [18] |
TSLP (5q22) | TSLP | Basophils chemo-attraction | [28,29] |
CAPN14 | Calpain 14 | Proteolytic effects | [28] |
- Citation: D’Alessandro A, Esposito D, Pesce M, Cuomo R, De Palma GD, Sarnelli G. Eosinophilic esophagitis: From pathophysiology to treatment. World J Gastrointest Pathophysiol 2015; 6(4): 150-158
- URL: https://www.wjgnet.com/2150-5330/full/v6/i4/150.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v6.i4.150